Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Biohaven Ltd (NYSE: BHVN) closed at $9.41 in the last session, down -2.79% from day before closing price of $9.68. In other words, the price has decreased by -$2.79 from its previous closing price. On the day, 2.63 million shares were traded. BHVN stock price reached its highest trading level at $9.57 during the session, while it also had its lowest trading level at $9.11.
Ratios:
We take a closer look at BHVN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.86 and its Current Ratio is at 2.86.
On November 05, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $10. On September 17, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $28.Citigroup initiated its Buy rating on September 17, 2025, with a $28 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 17 ’25 when Clark George C. bought 17,000 shares for $8.52 per share. The transaction valued at 144,770 led to the insider holds 20,000 shares of the business.
Bailey Gregory bought 400,000 shares of BHVN for $3,000,000 on Nov 13 ’25. The Director now owns 2,020,071 shares after completing the transaction at $7.50 per share. On Nov 13 ’25, another insider, CHILDS JOHN W, who serves as the Director of the company, bought 3,333,333 shares for $7.50 each. As a result, the insider paid 24,999,998 and bolstered with 5,653,904 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1248598656 and an Enterprise Value of 1050056000.
Stock Price History:
The Beta on a monthly basis for BHVN is 3.71, which has changed by -0.7912893 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $47.75, while it has fallen to a 52-week low of $7.48. The 50-Day Moving Average of the stock is -31.32%, while the 200-Day Moving Average is calculated to be -49.06%.
Shares Statistics:
According to the various share statistics, BHVN traded on average about 3.55M shares per day over the past 3-months and 5917730 shares per day over the past 10 days. A total of 105.80M shares are outstanding, with a floating share count of 88.59M. Insiders hold about 16.31% of the company’s shares, while institutions hold 82.00% stake in the company. Shares short for BHVN as of 1763078400 were 13125722 with a Short Ratio of 2.72, compared to 1760486400 on 10304537. Therefore, it implies a Short% of Shares Outstanding of 13125722 and a Short% of Float of 10.850000399999999.
Earnings Estimates
The performance of Biohaven Ltd (BHVN) in the stock market is under the watchful eye of 4.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$1.27, with high estimates of -$0.83 and low estimates of -$1.7.
Analysts are recommending an EPS of between -$5.56 and -$5.91 for the fiscal current year, implying an average EPS of -$5.74. EPS for the following year is -$4.17, with 6.0 analysts recommending between -$2.49 and -$6.37.
